

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 9.72215628 |
| 2 | regulation of mast cell degranulation (GO:0043304) | 9.64345114 |
| 3 | leukotriene biosynthetic process (GO:0019370) | 9.49773541 |
| 4 | positive regulation of regulated secretory pathway (GO:1903307) | 9.41460546 |
| 5 | regulation of mast cell activation involved in immune response (GO:0033006) | 9.11990077 |
| 6 | positive regulation of megakaryocyte differentiation (GO:0045654) | 8.95298966 |
| 7 | production of molecular mediator involved in inflammatory response (GO:0002532) | 8.25634812 |
| 8 | positive regulation of hematopoietic progenitor cell differentiation (GO:1901534) | 7.65254604 |
| 9 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 7.32401454 |
| 10 | regulation of leukocyte degranulation (GO:0043300) | 7.03240740 |
| 11 | regulation of mast cell activation (GO:0033003) | 6.95594624 |
| 12 | peptide hormone processing (GO:0016486) | 6.76444405 |
| 13 | leukotriene metabolic process (GO:0006691) | 6.02703994 |
| 14 | regulation of regulated secretory pathway (GO:1903305) | 5.91717356 |
| 15 | serotonin metabolic process (GO:0042428) | 5.78663178 |
| 16 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 5.46884733 |
| 17 | tyrosine phosphorylation of STAT protein (GO:0007260) | 5.30416803 |
| 18 | cytokine biosynthetic process (GO:0042089) | 5.27472260 |
| 19 | regulation of cellular extravasation (GO:0002691) | 5.25143448 |
| 20 | monoamine transport (GO:0015844) | 5.25133005 |
| 21 | positive regulation of chemokine secretion (GO:0090197) | 5.12561955 |
| 22 | positive regulation of acute inflammatory response (GO:0002675) | 5.12028954 |
| 23 | cytokine metabolic process (GO:0042107) | 5.02944224 |
| 24 | positive regulation of respiratory burst (GO:0060267) | 4.98005802 |
| 25 | primary amino compound metabolic process (GO:1901160) | 4.85817586 |
| 26 | glomerular filtration (GO:0003094) | 4.73692818 |
| 27 | complement activation, classical pathway (GO:0006958) | 4.54805820 |
| 28 | thrombin receptor signaling pathway (GO:0070493) | 4.53620553 |
| 29 | antimicrobial humoral response (GO:0019730) | 4.52013209 |
| 30 | antibacterial humoral response (GO:0019731) | 4.37184108 |
| 31 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 4.36680550 |
| 32 | positive regulation of B cell mediated immunity (GO:0002714) | 4.36680550 |
| 33 | positive regulation of calcium-mediated signaling (GO:0050850) | 4.25806659 |
| 34 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 4.22885001 |
| 35 | fatty acid derivative biosynthetic process (GO:1901570) | 4.20749041 |
| 36 | icosanoid biosynthetic process (GO:0046456) | 4.20749041 |
| 37 | renal filtration (GO:0097205) | 4.15868829 |
| 38 | complement activation (GO:0006956) | 4.13999828 |
| 39 | regulation of guanylate cyclase activity (GO:0031282) | 4.13840419 |
| 40 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 4.11981228 |
| 41 | positive regulation of antigen processing and presentation (GO:0002579) | 4.04951392 |
| 42 | mast cell degranulation (GO:0043303) | 3.98693657 |
| 43 | mast cell activation involved in immune response (GO:0002279) | 3.98693657 |
| 44 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.91384126 |
| 45 | regulation of megakaryocyte differentiation (GO:0045652) | 3.89500657 |
| 46 | positive regulation of pseudopodium assembly (GO:0031274) | 3.88147956 |
| 47 | NADH metabolic process (GO:0006734) | 3.87118493 |
| 48 | regulation of chemokine secretion (GO:0090196) | 3.86262823 |
| 49 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.86256719 |
| 50 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.84990076 |
| 51 | positive regulation of exocytosis (GO:0045921) | 3.79479616 |
| 52 | bone remodeling (GO:0046849) | 3.78685483 |
| 53 | regulation of respiratory burst (GO:0060263) | 3.73388479 |
| 54 | mammary gland alveolus development (GO:0060749) | 3.71637785 |
| 55 | immunoglobulin mediated immune response (GO:0016064) | 3.71482333 |
| 56 | peptide catabolic process (GO:0043171) | 3.67416212 |
| 57 | indolalkylamine metabolic process (GO:0006586) | 3.64724939 |
| 58 | regulation of antigen processing and presentation (GO:0002577) | 3.59342696 |
| 59 | lipoxygenase pathway (GO:0019372) | 3.57964983 |
| 60 | cytokine production involved in immune response (GO:0002367) | 3.56515245 |
| 61 | positive regulation of tyrosine phosphorylation of Stat1 protein (GO:0042511) | 3.54541750 |
| 62 | unsaturated fatty acid biosynthetic process (GO:0006636) | 3.51236249 |
| 63 | regulation of pseudopodium assembly (GO:0031272) | 3.48986345 |
| 64 | virion attachment to host cell (GO:0019062) | 3.36888882 |
| 65 | adhesion of symbiont to host cell (GO:0044650) | 3.36888882 |
| 66 | actin nucleation (GO:0045010) | 3.36874251 |
| 67 | eosinophil migration (GO:0072677) | 3.36589237 |
| 68 | detection of bacterium (GO:0016045) | 3.35507406 |
| 69 | mast cell activation (GO:0045576) | 3.33020694 |
| 70 | eosinophil chemotaxis (GO:0048245) | 3.31807212 |
| 71 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.28259215 |
| 72 | regulation of vitamin metabolic process (GO:0030656) | 3.26693534 |
| 73 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.21797547 |
| 74 | regulation of B cell mediated immunity (GO:0002712) | 3.18580481 |
| 75 | detection of other organism (GO:0098543) | 3.17987397 |
| 76 | activation of JUN kinase activity (GO:0007257) | 3.17107507 |
| 77 | positive regulation of guanylate cyclase activity (GO:0031284) | 3.15332405 |
| 78 | definitive hemopoiesis (GO:0060216) | 3.14520194 |
| 79 | glycosphingolipid catabolic process (GO:0046479) | 3.10940336 |
| 80 | cellular biogenic amine biosynthetic process (GO:0042401) | 3.05592143 |
| 81 | amine biosynthetic process (GO:0009309) | 3.05592143 |
| 82 | protein activation cascade (GO:0072376) | 3.05347605 |
| 83 | regulation of immunoglobulin mediated immune response (GO:0002889) | 3.05054275 |
| 84 | intestinal absorption (GO:0050892) | 3.04795295 |
| 85 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 3.03985239 |
| 86 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.02236076 |
| 87 | glycolipid catabolic process (GO:0019377) | 3.01273800 |
| 88 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 2.96350972 |
| 89 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 2.95390156 |
| 90 | regulation of calcium-mediated signaling (GO:0050848) | 2.92198751 |
| 91 | heparin metabolic process (GO:0030202) | 2.91536487 |
| 92 | heparin biosynthetic process (GO:0030210) | 2.91536487 |
| 93 | fructose metabolic process (GO:0006000) | 2.91199749 |
| 94 | humoral immune response (GO:0006959) | 2.90868982 |
| 95 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.88939146 |
| 96 | germ cell migration (GO:0008354) | 2.84366866 |
| 97 | cellular response to glucose stimulus (GO:0071333) | 2.83894715 |
| 98 | positive regulation of macrophage differentiation (GO:0045651) | 2.82699782 |
| 99 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.82604481 |
| 100 | response to nitric oxide (GO:0071731) | 2.80845452 |
| 101 | diacylglycerol metabolic process (GO:0046339) | 2.79737182 |
| 102 | hormone catabolic process (GO:0042447) | 2.79025096 |
| 103 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 2.78667580 |
| 104 | adhesion of symbiont to host (GO:0044406) | 2.77794051 |
| 105 | transcytosis (GO:0045056) | 2.76897040 |
| 106 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.74644142 |
| 107 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.74644142 |
| 108 | regulation of cGMP biosynthetic process (GO:0030826) | 2.74636620 |
| 109 | NIK/NF-kappaB signaling (GO:0038061) | 2.72744274 |
| 110 | megakaryocyte development (GO:0035855) | 2.70846709 |
| 111 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 2.70542834 |
| 112 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.70185888 |
| 113 | urea cycle (GO:0000050) | 2.68750791 |
| 114 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 2.66280789 |
| 115 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 2.66280789 |
| 116 | endocrine process (GO:0050886) | 2.66280789 |
| 117 | cellular response to hexose stimulus (GO:0071331) | 2.65920338 |
| 118 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.65886877 |
| 119 | cellular response to nitric oxide (GO:0071732) | 2.65430565 |
| 120 | cellular response to reactive nitrogen species (GO:1902170) | 2.63426369 |
| 121 | surfactant homeostasis (GO:0043129) | 2.63175107 |
| 122 | regulation of macrophage differentiation (GO:0045649) | 2.62986089 |
| 123 | neutrophil activation involved in immune response (GO:0002283) | 2.62877762 |
| 124 | cyclooxygenase pathway (GO:0019371) | 2.60831868 |
| 125 | low-density lipoprotein particle remodeling (GO:0034374) | 2.60512693 |
| 126 | regulation of acute inflammatory response (GO:0002673) | 2.60507782 |
| 127 | defense response to fungus (GO:0050832) | 2.59626781 |
| 128 | ethanol oxidation (GO:0006069) | 2.58860560 |
| 129 | cellular response to monosaccharide stimulus (GO:0071326) | 2.58399421 |
| 130 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.56779316 |
| 131 | B cell mediated immunity (GO:0019724) | 2.54665398 |
| 132 | midbrain development (GO:0030901) | 2.52932143 |
| 133 | negative regulation of meiosis (GO:0045835) | 2.52842189 |
| 134 | keratinization (GO:0031424) | 2.52695173 |
| 135 | ceramide catabolic process (GO:0046514) | 2.52431654 |
| 136 | regulation of tyrosine phosphorylation of Stat1 protein (GO:0042510) | 2.52372759 |
| 137 | epoxygenase P450 pathway (GO:0019373) | 2.51460017 |
| 138 | positive regulation of granulocyte chemotaxis (GO:0071624) | 2.50788326 |
| 139 | lipoprotein transport (GO:0042953) | 2.50694622 |
| 140 | positive regulation of glycoprotein metabolic process (GO:1903020) | 2.47417722 |
| 141 | urea metabolic process (GO:0019627) | 2.46877404 |
| 142 | indole-containing compound metabolic process (GO:0042430) | 2.46220353 |
| 143 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.46042041 |
| 144 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.43930062 |
| 145 | mannose metabolic process (GO:0006013) | 2.43670252 |
| 146 | negative regulation of granulocyte differentiation (GO:0030853) | 2.41759242 |
| 147 | mature B cell differentiation involved in immune response (GO:0002313) | 2.41051995 |
| 148 | positive regulation of B cell differentiation (GO:0045579) | 2.40404306 |
| 149 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.39356167 |
| 150 | regulation of gamma-delta T cell activation (GO:0046643) | 2.39353193 |
| 151 | dendritic cell chemotaxis (GO:0002407) | 2.39188768 |
| 152 | production of molecular mediator of immune response (GO:0002440) | 2.38926692 |
| 153 | positive regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033141) | 2.38893817 |
| 154 | regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033139) | 2.38893817 |
| 155 | T-helper 1 type immune response (GO:0042088) | 2.38263020 |
| 156 | cellular response to zinc ion (GO:0071294) | 2.38046940 |
| 157 | negative regulation of leukocyte migration (GO:0002686) | 2.37056756 |
| 158 | nitrogen cycle metabolic process (GO:0071941) | 2.36408380 |
| 159 | phosphatidylglycerol acyl-chain remodeling (GO:0036148) | 2.35991590 |
| 160 | negative regulation of macrophage differentiation (GO:0045650) | 2.35879761 |
| 161 | adenosine receptor signaling pathway (GO:0001973) | 2.35415521 |
| 162 | regulation of T cell migration (GO:2000404) | 2.35220058 |
| 163 | cellular response to cadmium ion (GO:0071276) | 2.35092794 |
| 164 | regulation of necrotic cell death (GO:0010939) | 2.34596999 |
| 165 | positive regulation of systemic arterial blood pressure (GO:0003084) | 2.33786392 |
| 166 | cellular response to exogenous dsRNA (GO:0071360) | 2.33147798 |
| 167 | aromatic amino acid family metabolic process (GO:0009072) | 2.32376313 |
| 168 | actin filament capping (GO:0051693) | 2.31387431 |
| 169 | lung lobe morphogenesis (GO:0060463) | 2.28882901 |
| 170 | relaxation of smooth muscle (GO:0044557) | 2.28313546 |
| 171 | positive regulation of leukocyte mediated immunity (GO:0002705) | 2.26863402 |
| 172 | cellular response to carbohydrate stimulus (GO:0071322) | 2.22593746 |
| 173 | regulation of hematopoietic progenitor cell differentiation (GO:1901532) | 2.19499146 |
| 174 | positive regulation of astrocyte differentiation (GO:0048711) | 2.19211179 |
| 175 | positive regulation of macrophage activation (GO:0043032) | 2.15704059 |
| 176 | response to corticosterone (GO:0051412) | 2.11188752 |
| 177 | histamine secretion (GO:0001821) | 2.08621732 |
| 178 | lysosome localization (GO:0032418) | 2.08604699 |
| 179 | fatty acid derivative metabolic process (GO:1901568) | 2.08020390 |
| 180 | icosanoid metabolic process (GO:0006690) | 2.08020390 |
| 181 | cellular glucose homeostasis (GO:0001678) | 2.06219115 |
| 182 | negative regulation of complement activation (GO:0045916) | 2.02837691 |
| 183 | negative regulation of bone resorption (GO:0045779) | 2.02146198 |
| 184 | mating behavior (GO:0007617) | 2.01622978 |
| 185 | positive regulation of erythrocyte differentiation (GO:0045648) | 2.00497337 |
| 186 | angiotensin maturation (GO:0002003) | 17.8492639 |
| 187 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 17.7183927 |
| 188 | positive regulation of mast cell degranulation (GO:0043306) | 17.7183927 |
| 189 | regulation of hypersensitivity (GO:0002883) | 16.0491291 |
| 190 | positive regulation of mast cell activation (GO:0033005) | 14.7266015 |
| 191 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 14.4566421 |
| 192 | positive regulation of leukocyte degranulation (GO:0043302) | 13.2547416 |
| 193 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 11.4537303 |
| 194 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 11.0195484 |
| 195 | regulation of acute inflammatory response to antigenic stimulus (GO:0002864) | 11.0109329 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SCL_19346495_ChIP-Seq_HPC-7_Human | 4.76315237 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.60829100 |
| 3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.52201139 |
| 4 | EGR1_19032775_ChIP-ChIP_M12_Human | 3.41235870 |
| 5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.61035054 |
| 6 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.53321733 |
| 7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.51580510 |
| 8 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 2.44473832 |
| 9 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.43344457 |
| 10 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.33651451 |
| 11 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.21272197 |
| 12 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.18578838 |
| 13 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.13027384 |
| 14 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.03647232 |
| 15 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 13.3322681 |
| 16 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.99954477 |
| 17 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.99609998 |
| 18 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.96334502 |
| 19 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.90295069 |
| 20 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.88526372 |
| 21 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.79454592 |
| 22 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.76539809 |
| 23 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.76471298 |
| 24 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.74583010 |
| 25 | GATA1_19941826_ChIP-Seq_K562_Human | 1.74255243 |
| 26 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.74213434 |
| 27 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.70076910 |
| 28 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.69133954 |
| 29 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.68865171 |
| 30 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.68745617 |
| 31 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.68555272 |
| 32 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.66510282 |
| 33 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.66019223 |
| 34 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.65663093 |
| 35 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.62546370 |
| 36 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.58802518 |
| 37 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.58186668 |
| 38 | GATA1_22025678_ChIP-Seq_K562_Human | 1.56789641 |
| 39 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.53959808 |
| 40 | MAF_26560356_Chip-Seq_TH1_Human | 1.52304714 |
| 41 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.51202496 |
| 42 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.50963224 |
| 43 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.46911119 |
| 44 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.45021870 |
| 45 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.44771750 |
| 46 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.44459897 |
| 47 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.44306569 |
| 48 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.44295997 |
| 49 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.43709318 |
| 50 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.41728910 |
| 51 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.41476881 |
| 52 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.39906743 |
| 53 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.39711136 |
| 54 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.35139292 |
| 55 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.34421585 |
| 56 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.32949076 |
| 57 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.32376458 |
| 58 | SPI1_23127762_ChIP-Seq_K562_Human | 1.31919271 |
| 59 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.30360952 |
| 60 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.29519282 |
| 61 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.29148340 |
| 62 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.28704391 |
| 63 | TP53_16413492_ChIP-PET_HCT116_Human | 1.24443206 |
| 64 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.23981832 |
| 65 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.22640304 |
| 66 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.21295055 |
| 67 | SA1_27219007_Chip-Seq_Bcells_Human | 1.21014314 |
| 68 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.20549981 |
| 69 | GATA2_19941826_ChIP-Seq_K562_Human | 1.18899830 |
| 70 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.17943319 |
| 71 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.17812550 |
| 72 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.17703542 |
| 73 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.17544981 |
| 74 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.16822134 |
| 75 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.16546345 |
| 76 | MYC_22102868_ChIP-Seq_BL_Human | 1.16503820 |
| 77 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.15931242 |
| 78 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.15883679 |
| 79 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.15779697 |
| 80 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.14457555 |
| 81 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.13742481 |
| 82 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.13708242 |
| 83 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.13129444 |
| 84 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12611184 |
| 85 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.11777514 |
| 86 | P68_20966046_ChIP-Seq_HELA_Human | 1.09484201 |
| 87 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.07535652 |
| 88 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.07023081 |
| 89 | UTX_26944678_Chip-Seq_JUKART_Human | 1.06549409 |
| 90 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.05856991 |
| 91 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05738566 |
| 92 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.05580551 |
| 93 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.05188319 |
| 94 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.05088077 |
| 95 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.03980232 |
| 96 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.03779770 |
| 97 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.03717087 |
| 98 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.03565888 |
| 99 | KDM2B_26808549_Chip-Seq_K562_Human | 1.03325236 |
| 100 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.01775391 |
| 101 | MYB_26560356_Chip-Seq_TH1_Human | 1.01766113 |
| 102 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.01691586 |
| 103 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.01643453 |
| 104 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.01455543 |
| 105 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.99912964 |
| 106 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.99334612 |
| 107 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.98847436 |
| 108 | P300_27268052_Chip-Seq_Bcells_Human | 0.98049388 |
| 109 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.97852657 |
| 110 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.97644504 |
| 111 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97505867 |
| 112 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.96661564 |
| 113 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.94884088 |
| 114 | * CTCF_20526341_ChIP-Seq_ESCs_Human | 0.94632295 |
| 115 | MYB_26560356_Chip-Seq_TH2_Human | 0.93610445 |
| 116 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.93568042 |
| 117 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.92345078 |
| 118 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.90879497 |
| 119 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.89668689 |
| 120 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.89338346 |
| 121 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.88844117 |
| 122 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.88582816 |
| 123 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.88087865 |
| 124 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.86603186 |
| 125 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.86603186 |
| 126 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.86603186 |
| 127 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.86437965 |
| 128 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.85042647 |
| 129 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.85019129 |
| 130 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.84605404 |
| 131 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.84553923 |
| 132 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.84115950 |
| 133 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.83728135 |
| 134 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.83277423 |
| 135 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.82110836 |
| 136 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.82108830 |
| 137 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.82000891 |
| 138 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.81241856 |
| 139 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.81053795 |
| 140 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.80607772 |
| 141 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.80078307 |
| 142 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.76976501 |
| 143 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.76738833 |
| 144 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.76323915 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002877_abnormal_melanocyte_morpholog | 5.87928830 |
| 2 | MP0000465_gastrointestinal_hemorrhage | 4.74392285 |
| 3 | MP0008775_abnormal_heart_ventricle | 4.05448263 |
| 4 | MP0002148_abnormal_hypersensitivity_rea | 4.01311897 |
| 5 | MP0003638_abnormal_response/metabolism_ | 3.62562691 |
| 6 | MP0004808_abnormal_hematopoietic_stem | 3.27574979 |
| 7 | MP0005464_abnormal_platelet_physiology | 3.23488088 |
| 8 | MP0003436_decreased_susceptibility_to | 3.14820072 |
| 9 | MP0009379_abnormal_foot_pigmentation | 3.08413858 |
| 10 | MP0003724_increased_susceptibility_to | 3.00783088 |
| 11 | MP0003566_abnormal_cell_adhesion | 2.95908734 |
| 12 | MP0010155_abnormal_intestine_physiology | 2.86973056 |
| 13 | MP0009765_abnormal_xenobiotic_induced | 2.85686272 |
| 14 | MP0001835_abnormal_antigen_presentation | 2.59228434 |
| 15 | MP0003300_gastrointestinal_ulcer | 2.54241737 |
| 16 | MP0004147_increased_porphyrin_level | 2.43170251 |
| 17 | MP0010234_abnormal_vibrissa_follicle | 2.41512535 |
| 18 | MP0004782_abnormal_surfactant_physiolog | 2.34563799 |
| 19 | MP0005058_abnormal_lysosome_morphology | 2.25931694 |
| 20 | MP0003303_peritoneal_inflammation | 2.20221460 |
| 21 | MP0002419_abnormal_innate_immunity | 2.19714791 |
| 22 | MP0010329_abnormal_lipoprotein_level | 2.14405996 |
| 23 | MP0009785_altered_susceptibility_to | 2.05648335 |
| 24 | MP0005387_immune_system_phenotype | 2.00960406 |
| 25 | MP0001790_abnormal_immune_system | 2.00960406 |
| 26 | MP0002398_abnormal_bone_marrow | 2.00301652 |
| 27 | MP0001800_abnormal_humoral_immune | 1.99408484 |
| 28 | MP0005367_renal/urinary_system_phenotyp | 1.93546632 |
| 29 | MP0000516_abnormal_urinary_system | 1.93546632 |
| 30 | MP0001666_abnormal_nutrient_absorption | 1.90951952 |
| 31 | MP0005000_abnormal_immune_tolerance | 1.89290808 |
| 32 | MP0000249_abnormal_blood_vessel | 1.88980955 |
| 33 | MP0002796_impaired_skin_barrier | 1.87129394 |
| 34 | MP0005646_abnormal_pituitary_gland | 1.85500612 |
| 35 | * MP0002420_abnormal_adaptive_immunity | 1.82948753 |
| 36 | * MP0001819_abnormal_immune_cell | 1.82222661 |
| 37 | MP0000685_abnormal_immune_system | 1.80911296 |
| 38 | MP0004885_abnormal_endolymph | 1.80485645 |
| 39 | MP0008873_increased_physiological_sensi | 1.74558063 |
| 40 | MP0001873_stomach_inflammation | 1.74545181 |
| 41 | MP0006082_CNS_inflammation | 1.72790016 |
| 42 | MP0005409_darkened_coat_color | 1.67650561 |
| 43 | MP0004019_abnormal_vitamin_homeostasis | 1.67585900 |
| 44 | MP0004858_abnormal_nervous_system | 1.65952450 |
| 45 | MP0002723_abnormal_immune_serum | 1.61145355 |
| 46 | MP0002909_abnormal_adrenal_gland | 1.59714339 |
| 47 | MP0001533_abnormal_skeleton_physiology | 1.52392446 |
| 48 | MP0001970_abnormal_pain_threshold | 1.52223853 |
| 49 | MP0005671_abnormal_response_to | 1.49497864 |
| 50 | MP0001663_abnormal_digestive_system | 1.47940583 |
| 51 | MP0003183_abnormal_peptide_metabolism | 1.46472969 |
| 52 | MP0002733_abnormal_thermal_nociception | 1.45723810 |
| 53 | MP0005365_abnormal_bile_salt | 1.42069291 |
| 54 | MP0002452_abnormal_antigen_presenting | 1.41355029 |
| 55 | MP0005085_abnormal_gallbladder_physiolo | 1.41342150 |
| 56 | MP0003329_amyloid_beta_deposits | 1.40779083 |
| 57 | MP0005623_abnormal_meninges_morphology | 1.40709556 |
| 58 | MP0002722_abnormal_immune_system | 1.39345536 |
| 59 | MP0005174_abnormal_tail_pigmentation | 1.38384434 |
| 60 | * MP0005025_abnormal_response_to | 1.35576503 |
| 61 | MP0004264_abnormal_extraembryonic_tissu | 1.35022127 |
| 62 | MP0002166_altered_tumor_susceptibility | 1.34887497 |
| 63 | MP0008770_decreased_survivor_rate | 1.33405053 |
| 64 | MP0004924_abnormal_behavior | 1.30720635 |
| 65 | MP0005386_behavior/neurological_phenoty | 1.30720635 |
| 66 | MP0008469_abnormal_protein_level | 1.29892593 |
| 67 | MP0009763_increased_sensitivity_to | 1.28136377 |
| 68 | MP0002405_respiratory_system_inflammati | 1.26630154 |
| 69 | MP0000716_abnormal_immune_system | 1.26142967 |
| 70 | MP0003866_abnormal_defecation | 1.24722167 |
| 71 | MP0005275_abnormal_skin_tensile | 1.23606942 |
| 72 | MP0002254_reproductive_system_inflammat | 1.22708414 |
| 73 | MP0004510_myositis | 1.21806223 |
| 74 | MP0002138_abnormal_hepatobiliary_system | 1.21223131 |
| 75 | MP0000343_altered_response_to | 1.19833147 |
| 76 | MP0009840_abnormal_foam_cell | 1.19312821 |
| 77 | MP0009643_abnormal_urine_homeostasis | 1.19268685 |
| 78 | MP0002429_abnormal_blood_cell | 1.18404903 |
| 79 | MP0004859_abnormal_synaptic_plasticity | 1.18010481 |
| 80 | MP0008004_abnormal_stomach_pH | 1.17646905 |
| 81 | MP0002998_abnormal_bone_remodeling | 1.17591167 |
| 82 | MP0001664_abnormal_digestion | 1.15955719 |
| 83 | MP0010307_abnormal_tumor_latency | 1.14911727 |
| 84 | MP0010352_gastrointestinal_tract_polyps | 1.12542046 |
| 85 | MP0000490_abnormal_crypts_of | 1.12126233 |
| 86 | MP0001958_emphysema | 1.11945255 |
| 87 | MP0005381_digestive/alimentary_phenotyp | 1.08634214 |
| 88 | MP0001188_hyperpigmentation | 1.08593491 |
| 89 | MP0003705_abnormal_hypodermis_morpholog | 1.05874280 |
| 90 | MP0005670_abnormal_white_adipose | 1.05632880 |
| 91 | MP0001764_abnormal_homeostasis | 1.05307520 |
| 92 | MP0005666_abnormal_adipose_tissue | 1.05198650 |
| 93 | MP0004085_abnormal_heartbeat | 1.04946585 |
| 94 | MP0008874_decreased_physiological_sensi | 1.00720814 |
| 95 | MP0001845_abnormal_inflammatory_respons | 0.99293488 |
| 96 | MP0005535_abnormal_body_temperature | 0.98885383 |
| 97 | MP0000604_amyloidosis | 0.97301100 |
| 98 | MP0002876_abnormal_thyroid_physiology | 0.96787807 |
| 99 | MP0005167_abnormal_blood-brain_barrier | 0.96776830 |
| 100 | MP0003453_abnormal_keratinocyte_physiol | 0.96737304 |
| 101 | MP0002933_joint_inflammation | 0.95811429 |
| 102 | MP0005075_abnormal_melanosome_morpholog | 0.95511835 |
| 103 | MP0003448_altered_tumor_morphology | 0.95410262 |
| 104 | MP0001765_abnormal_ion_homeostasis | 0.94404558 |
| 105 | MP0005390_skeleton_phenotype | 0.93203379 |
| 106 | MP0002971_abnormal_brown_adipose | 0.93172652 |
| 107 | MP0005165_increased_susceptibility_to | 0.93021052 |
| 108 | MP0000462_abnormal_digestive_system | 0.92773417 |
| 109 | MP0000477_abnormal_intestine_morphology | 0.92730528 |
| 110 | MP0004883_abnormal_blood_vessel | 0.92197613 |
| 111 | MP0003828_pulmonary_edema | 0.91489546 |
| 112 | MP0002396_abnormal_hematopoietic_system | 0.90940601 |
| 113 | MP0002139_abnormal_hepatobiliary_system | 0.90486015 |
| 114 | MP0004947_skin_inflammation | 0.90306948 |
| 115 | MP0000703_abnormal_thymus_morphology | 0.90171399 |
| 116 | MP0002118_abnormal_lipid_homeostasis | 0.89724425 |
| 117 | MP0009780_abnormal_chondrocyte_physiolo | 0.88727868 |
| 118 | MP0001851_eye_inflammation | 0.88276239 |
| 119 | MP0001727_abnormal_embryo_implantation | 0.88161960 |
| 120 | MP0000689_abnormal_spleen_morphology | 0.87986621 |
| 121 | MP0009115_abnormal_fat_cell | 0.86970177 |
| 122 | MP0001501_abnormal_sleep_pattern | 0.86785924 |
| 123 | MP0005360_urolithiasis | 0.85186217 |
| 124 | MP0001853_heart_inflammation | 0.84887038 |
| 125 | MP0003191_abnormal_cellular_cholesterol | 0.84641375 |
| 126 | MP0003763_abnormal_thymus_physiology | 0.84630053 |
| 127 | MP0005334_abnormal_fat_pad | 0.84524691 |
| 128 | MP0002972_abnormal_cardiac_muscle | 0.83609494 |
| 129 | MP0005332_abnormal_amino_acid | 0.83140662 |
| 130 | MP0005501_abnormal_skin_physiology | 0.82934350 |
| 131 | MP0009333_abnormal_splenocyte_physiolog | 0.82833369 |
| 132 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.81037598 |
| 133 | MP0002136_abnormal_kidney_physiology | 0.80926352 |
| 134 | MP0009384_cardiac_valve_regurgitation | 0.79295407 |
| 135 | MP0005166_decreased_susceptibility_to | 0.78946221 |
| 136 | MP0004185_abnormal_adipocyte_glucose | 0.77890010 |
| 137 | MP0002128_abnormal_blood_circulation | 0.74912947 |
| 138 | MP0003806_abnormal_nucleotide_metabolis | 0.69736545 |
| 139 | MP0001849_ear_inflammation | 0.69163105 |
| 140 | MP0001545_abnormal_hematopoietic_system | 0.68569210 |
| 141 | MP0005397_hematopoietic_system_phenotyp | 0.68569210 |
| 142 | MP0003172_abnormal_lysosome_physiology | 0.68532436 |
| 143 | MP0009278_abnormal_bone_marrow | 0.63671062 |
| 144 | MP0008961_abnormal_basal_metabolism | 0.62832109 |
| 145 | MP0005310_abnormal_salivary_gland | 0.62796622 |
| 146 | MP0003795_abnormal_bone_structure | 0.61949133 |
| 147 | MP0005620_abnormal_muscle_contractility | 0.61455386 |
| 148 | MP0003075_altered_response_to | 0.61273322 |
| 149 | MP0008872_abnormal_physiological_respon | 0.60596455 |
| 150 | MP0009931_abnormal_skin_appearance | 0.59748332 |
| 151 | MP0003656_abnormal_erythrocyte_physiolo | 0.59461826 |
| 152 | MP0009764_decreased_sensitivity_to | 0.59068399 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased mean platelet volume (HP:0011877) | 9.63416673 |
| 2 | Abnormal platelet volume (HP:0011876) | 9.26785692 |
| 3 | Purpura (HP:0000979) | 9.06272923 |
| 4 | Menorrhagia (HP:0000132) | 8.87281099 |
| 5 | Prolonged bleeding time (HP:0003010) | 8.71376504 |
| 6 | Impaired platelet aggregation (HP:0003540) | 7.97213835 |
| 7 | Abnormal platelet function (HP:0011869) | 7.97213835 |
| 8 | Gingival bleeding (HP:0000225) | 7.55631625 |
| 9 | Systemic lupus erythematosus (HP:0002725) | 6.26577811 |
| 10 | Malnutrition (HP:0004395) | 5.05954378 |
| 11 | Papilledema (HP:0001085) | 4.64921181 |
| 12 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.62137852 |
| 13 | Epistaxis (HP:0000421) | 4.49715633 |
| 14 | Increased IgE level (HP:0003212) | 4.33645672 |
| 15 | Aplastic anemia (HP:0001915) | 4.27211666 |
| 16 | Eczematoid dermatitis (HP:0000976) | 4.17908319 |
| 17 | Abnormality of complement system (HP:0005339) | 3.90334470 |
| 18 | Complement deficiency (HP:0004431) | 3.86477722 |
| 19 | Glomerulonephritis (HP:0000099) | 3.66854074 |
| 20 | Interstitial pulmonary disease (HP:0006530) | 3.37152542 |
| 21 | Decreased circulating renin level (HP:0003351) | 3.27033577 |
| 22 | Chronic diarrhea (HP:0002028) | 3.25986647 |
| 23 | Bruising susceptibility (HP:0000978) | 3.23379484 |
| 24 | Cellulitis (HP:0100658) | 3.21555460 |
| 25 | Abnormality of macrophages (HP:0004311) | 3.15511885 |
| 26 | Abnormal sex determination (HP:0012244) | 3.10306820 |
| 27 | Sex reversal (HP:0012245) | 3.10306820 |
| 28 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.10191629 |
| 29 | Abnormality of proline metabolism (HP:0010907) | 3.07270563 |
| 30 | Hydroxyprolinuria (HP:0003080) | 3.07270563 |
| 31 | Neoplasm of head and neck (HP:0012288) | 3.01539458 |
| 32 | Esophageal neoplasm (HP:0100751) | 3.01539458 |
| 33 | Abnormality of glycolipid metabolism (HP:0010969) | 2.96090826 |
| 34 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.96090826 |
| 35 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.96090826 |
| 36 | Abnormality of binocular vision (HP:0011514) | 2.92403110 |
| 37 | Diplopia (HP:0000651) | 2.92403110 |
| 38 | Chronic otitis media (HP:0000389) | 2.79353009 |
| 39 | Poikilocytosis (HP:0004447) | 2.79056045 |
| 40 | Myositis (HP:0100614) | 2.78389634 |
| 41 | Dysostosis multiplex (HP:0000943) | 2.77443961 |
| 42 | White forelock (HP:0002211) | 2.71168370 |
| 43 | Autoimmune thrombocytopenia (HP:0001973) | 2.68146790 |
| 44 | Cerebral palsy (HP:0100021) | 2.66043047 |
| 45 | Nephritis (HP:0000123) | 2.64309149 |
| 46 | Vacuolated lymphocytes (HP:0001922) | 2.63705726 |
| 47 | Recurrent bacterial skin infections (HP:0005406) | 2.61184218 |
| 48 | Insomnia (HP:0100785) | 2.60497681 |
| 49 | Nausea (HP:0002018) | 2.60194308 |
| 50 | Agammaglobulinemia (HP:0004432) | 2.56697036 |
| 51 | Abnormality of the nasal mucosa (HP:0000433) | 2.55800941 |
| 52 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.54559951 |
| 53 | Hypergammaglobulinemia (HP:0010702) | 2.54482499 |
| 54 | Ileus (HP:0002595) | 2.52237614 |
| 55 | Cerebral aneurysm (HP:0004944) | 2.50652118 |
| 56 | Gingivitis (HP:0000230) | 2.49284624 |
| 57 | Obstructive lung disease (HP:0006536) | 2.46644278 |
| 58 | Chronic obstructive pulmonary disease (HP:0006510) | 2.46644278 |
| 59 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.46053498 |
| 60 | Slender build (HP:0001533) | 2.42533243 |
| 61 | Amyloidosis (HP:0011034) | 2.39045670 |
| 62 | Supranuclear gaze palsy (HP:0000605) | 2.38965243 |
| 63 | Recurrent viral infections (HP:0004429) | 2.38494044 |
| 64 | Pustule (HP:0200039) | 2.37216742 |
| 65 | Neurofibrillary tangles (HP:0002185) | 2.37013810 |
| 66 | Gastrointestinal stroma tumor (HP:0100723) | 2.33653721 |
| 67 | Cerebral inclusion bodies (HP:0100314) | 2.33064759 |
| 68 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.32105473 |
| 69 | Vasculitis (HP:0002633) | 2.31977956 |
| 70 | Patchy hypopigmentation of hair (HP:0011365) | 2.30963327 |
| 71 | Recurrent abscess formation (HP:0002722) | 2.29211374 |
| 72 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.28655009 |
| 73 | Villous atrophy (HP:0011473) | 2.28655009 |
| 74 | Growth hormone excess (HP:0000845) | 2.28195476 |
| 75 | Orchitis (HP:0100796) | 2.27122122 |
| 76 | Meningitis (HP:0001287) | 2.24864061 |
| 77 | Skin rash (HP:0000988) | 2.23659571 |
| 78 | Hemoptysis (HP:0002105) | 2.18999199 |
| 79 | Widely patent fontanelles and sutures (HP:0004492) | 2.18001694 |
| 80 | Alopecia of scalp (HP:0002293) | 2.17514053 |
| 81 | Abnormality of renin-angiotensin system (HP:0000847) | 2.16193314 |
| 82 | Hemorrhage of the eye (HP:0011885) | 2.15228078 |
| 83 | Hyperactive renin-angiotensin system (HP:0000841) | 2.12071024 |
| 84 | Bone cyst (HP:0012062) | 2.11581947 |
| 85 | Mediastinal lymphadenopathy (HP:0100721) | 2.09877219 |
| 86 | Erythema (HP:0010783) | 2.09245247 |
| 87 | Polygenic inheritance (HP:0010982) | 2.09218025 |
| 88 | Hyperacusis (HP:0010780) | 2.08156538 |
| 89 | Alkalosis (HP:0001948) | 2.07673163 |
| 90 | Pulmonary infiltrates (HP:0002113) | 2.07502481 |
| 91 | Abnormality of oral frenula (HP:0000190) | 2.06864649 |
| 92 | Osteomyelitis (HP:0002754) | 2.06178589 |
| 93 | Palmoplantar hyperkeratosis (HP:0000972) | 2.05545673 |
| 94 | Recurrent cutaneous fungal infections (HP:0011370) | 2.03623946 |
| 95 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.03623946 |
| 96 | Encephalitis (HP:0002383) | 2.01688979 |
| 97 | Petechiae (HP:0000967) | 11.9928550 |
| 98 | Heterochromia iridis (HP:0001100) | 1.95532843 |
| 99 | Thin bony cortex (HP:0002753) | 1.95486574 |
| 100 | Metabolic alkalosis (HP:0200114) | 1.94892392 |
| 101 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.94803109 |
| 102 | Premature loss of primary teeth (HP:0006323) | 1.93866698 |
| 103 | Emphysema (HP:0002097) | 1.93551792 |
| 104 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.93181973 |
| 105 | Hypophosphatemia (HP:0002148) | 1.92867525 |
| 106 | Abnormality of T cell physiology (HP:0011840) | 1.92143924 |
| 107 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.91471176 |
| 108 | Congenital sensorineural hearing impairment (HP:0008527) | 1.90824790 |
| 109 | Axonal loss (HP:0003447) | 1.90709514 |
| 110 | Panhypogammaglobulinemia (HP:0003139) | 1.90672316 |
| 111 | Urticaria (HP:0001025) | 1.89411584 |
| 112 | Abnormality of B cell number (HP:0010975) | 1.89169407 |
| 113 | Germ cell neoplasia (HP:0100728) | 1.88190891 |
| 114 | Hematochezia (HP:0002573) | 1.88098541 |
| 115 | Deep venous thrombosis (HP:0002625) | 1.87670620 |
| 116 | Apathy (HP:0000741) | 1.85678000 |
| 117 | Mucopolysacchariduria (HP:0008155) | 1.81048930 |
| 118 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.81048930 |
| 119 | Acute myeloid leukemia (HP:0004808) | 1.79693770 |
| 120 | Recurrent fungal infections (HP:0002841) | 1.76725513 |
| 121 | Ankyloglossia (HP:0010296) | 1.70799038 |
| 122 | Diminished motivation (HP:0000745) | 1.68701309 |
| 123 | Disproportionate tall stature (HP:0001519) | 1.66698938 |
| 124 | Shallow orbits (HP:0000586) | 1.64577501 |
| 125 | Renal salt wasting (HP:0000127) | 1.63777819 |
| 126 | Xanthomatosis (HP:0000991) | 1.62730145 |
| 127 | IgM deficiency (HP:0002850) | 1.55705270 |
| 128 | Leukocytosis (HP:0001974) | 1.55096393 |
| 129 | Inflammation of the large intestine (HP:0002037) | 1.53806981 |
| 130 | Increased density of long bones (HP:0006392) | 1.53798077 |
| 131 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.53760373 |
| 132 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.53760373 |
| 133 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.53760373 |
| 134 | Abnormality of the Achilles tendon (HP:0005109) | 1.52720565 |
| 135 | Joint hemorrhage (HP:0005261) | 1.51678516 |
| 136 | Fibroma (HP:0010614) | 1.50661344 |
| 137 | Spontaneous hematomas (HP:0007420) | 1.49580250 |
| 138 | Achilles tendon contracture (HP:0001771) | 1.48814798 |
| 139 | Polycythemia (HP:0001901) | 1.48733001 |
| 140 | Striae distensae (HP:0001065) | 1.48337508 |
| 141 | Hyperaldosteronism (HP:0000859) | 1.47777206 |
| 142 | Global brain atrophy (HP:0002283) | 1.46691197 |
| 143 | Gastrointestinal inflammation (HP:0004386) | 1.46365937 |
| 144 | Aortic aneurysm (HP:0004942) | 1.44834052 |
| 145 | Fibrous tissue neoplasm (HP:0012316) | 1.42139056 |
| 146 | Gonadal dysgenesis (HP:0000133) | 1.41603977 |
| 147 | Recurrent skin infections (HP:0001581) | 1.41094915 |
| 148 | Increased cerebral lipofuscin (HP:0011813) | 1.38560109 |
| 149 | Colitis (HP:0002583) | 1.38377476 |
| 150 | Hemiplegia (HP:0002301) | 1.38060907 |
| 151 | Acrocyanosis (HP:0001063) | 1.37023558 |
| 152 | Adrenal overactivity (HP:0002717) | 1.36987464 |
| 153 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.36809497 |
| 154 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.36625435 |
| 155 | Overriding aorta (HP:0002623) | 1.35788399 |
| 156 | Large hands (HP:0001176) | 1.33870555 |
| 157 | Bronchomalacia (HP:0002780) | 1.33575008 |
| 158 | Nasal polyposis (HP:0100582) | 1.33404027 |
| 159 | Severe short stature (HP:0003510) | 1.33336224 |
| 160 | Cervical subluxation (HP:0003308) | 1.32327967 |
| 161 | Neoplasm of the rectum (HP:0100743) | 1.32221297 |
| 162 | Sudden cardiac death (HP:0001645) | 1.31590356 |
| 163 | Thoracolumbar scoliosis (HP:0002944) | 1.30739190 |
| 164 | Myocardial infarction (HP:0001658) | 1.29891798 |
| 165 | Abnormality of the lower motor neuron (HP:0002366) | 1.29813768 |
| 166 | Arterial tortuosity (HP:0005116) | 1.29410335 |
| 167 | Elfin facies (HP:0004428) | 1.29333622 |
| 168 | Renovascular hypertension (HP:0100817) | 1.27772534 |
| 169 | Increased connective tissue (HP:0009025) | 1.26412924 |
| 170 | Hypercortisolism (HP:0001578) | 1.26197723 |
| 171 | Lymphedema (HP:0001004) | 1.25557819 |
| 172 | Mitral stenosis (HP:0001718) | 1.24999012 |
| 173 | Mitral valve prolapse (HP:0001634) | 1.24314582 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KIT | 6.87650170 |
| 2 | MATK | 4.26602088 |
| 3 | RIPK4 | 3.52825567 |
| 4 | EEF2K | 3.45184198 |
| 5 | FES | 3.20506366 |
| 6 | MAP4K1 | 3.07437339 |
| 7 | ACVR1B | 2.96736604 |
| 8 | TRIB3 | 2.64246208 |
| 9 | CDK6 | 2.49162948 |
| 10 | NTRK2 | 2.40684314 |
| 11 | TXK | 2.38705574 |
| 12 | BLK | 2.17428482 |
| 13 | FLT3 | 1.97982560 |
| 14 | PRPF4B | 1.90119467 |
| 15 | GRK6 | 1.80481517 |
| 16 | TGFBR2 | 1.73211738 |
| 17 | TYK2 | 1.72002328 |
| 18 | PIM2 | 1.71980796 |
| 19 | MAPKAPK5 | 1.69392172 |
| 20 | FGFR2 | 1.66924532 |
| 21 | CSF1R | 1.66780220 |
| 22 | EPHA3 | 1.66343986 |
| 23 | ZAP70 | 1.62533881 |
| 24 | SYK | 1.62014931 |
| 25 | MAPK15 | 1.53773475 |
| 26 | PKN2 | 1.51799133 |
| 27 | MAP3K14 | 1.47034408 |
| 28 | MAPKAPK3 | 1.46519696 |
| 29 | SIK2 | 1.46145531 |
| 30 | FGFR4 | 1.43698331 |
| 31 | PTK6 | 1.42459468 |
| 32 | MAP3K1 | 1.41112944 |
| 33 | IKBKE | 1.38978801 |
| 34 | BMX | 1.37993515 |
| 35 | MST1R | 1.34988382 |
| 36 | EPHB2 | 1.34681019 |
| 37 | ITK | 1.34643264 |
| 38 | CSNK1G3 | 1.30726283 |
| 39 | IKBKB | 1.29929724 |
| 40 | PRKG2 | 1.28242394 |
| 41 | JAK2 | 1.25600483 |
| 42 | MAPKAPK2 | 1.24839502 |
| 43 | SIK1 | 1.24064616 |
| 44 | CAMK1G | 1.22948113 |
| 45 | PRKACG | 1.22239196 |
| 46 | NEK9 | 1.18115795 |
| 47 | CDC42BPA | 1.14317841 |
| 48 | LYN | 1.14191150 |
| 49 | KDR | 1.10815914 |
| 50 | TYRO3 | 1.10113332 |
| 51 | CAMK1D | 1.09337510 |
| 52 | MYLK | 1.09044438 |
| 53 | ABL2 | 1.07675168 |
| 54 | TAOK3 | 1.03724193 |
| 55 | MAP2K3 | 1.02167027 |
| 56 | DDR2 | 1.00042596 |
| 57 | CSNK1G2 | 0.99491074 |
| 58 | CAMKK2 | 0.99056320 |
| 59 | LRRK2 | 0.98667240 |
| 60 | MAP3K13 | 0.98311410 |
| 61 | TESK2 | 0.94621923 |
| 62 | PDPK1 | 0.94370989 |
| 63 | TRPM7 | 0.92415535 |
| 64 | ALK | 0.92149386 |
| 65 | PRKACB | 0.92070412 |
| 66 | CAMKK1 | 0.89176771 |
| 67 | MAP3K3 | 0.89139756 |
| 68 | HIPK2 | 0.88920893 |
| 69 | RPS6KB2 | 0.81862238 |
| 70 | IRAK1 | 0.80372988 |
| 71 | CSNK1G1 | 0.76702881 |
| 72 | BTK | 0.75649026 |
| 73 | STK10 | 0.73450495 |
| 74 | PDGFRA | 0.73440139 |
| 75 | MAP2K6 | 0.73365281 |
| 76 | IRAK3 | 0.72802081 |
| 77 | FER | 0.72616016 |
| 78 | BMPR2 | 0.70753420 |
| 79 | RPS6KL1 | 0.70692587 |
| 80 | RPS6KC1 | 0.70692587 |
| 81 | SCYL2 | 0.69865747 |
| 82 | HCK | 0.69404469 |
| 83 | NME1 | 0.66058060 |
| 84 | PAK2 | 0.65835769 |
| 85 | GRK7 | 0.64191257 |
| 86 | PDK1 | 0.62822153 |
| 87 | RPS6KA6 | 0.62521539 |
| 88 | PIK3CA | 0.61179732 |
| 89 | IRAK4 | 0.60613457 |
| 90 | EPHA2 | 0.60569841 |
| 91 | MAPK7 | 0.60428700 |
| 92 | TESK1 | 0.60220660 |
| 93 | TEC | 0.59472624 |
| 94 | RPS6KA2 | 0.59344845 |
| 95 | MAP2K1 | 0.58489652 |
| 96 | MAP3K7 | 0.58325411 |
| 97 | MAP3K11 | 0.58259350 |
| 98 | TAOK2 | 0.57560367 |
| 99 | NLK | 0.56654119 |
| 100 | FGFR3 | 0.56529392 |
| 101 | PIK3CG | 0.55746770 |
| 102 | NME2 | 0.55298790 |
| 103 | JAK1 | 0.55293011 |
| 104 | TGFBR1 | 0.55252315 |
| 105 | LCK | 0.54281174 |
| 106 | SRC | 0.53868664 |
| 107 | PRKAA2 | 0.53371951 |
| 108 | TIE1 | 0.53052824 |
| 109 | UHMK1 | 0.52898694 |
| 110 | DYRK1B | 0.52788547 |
| 111 | PRKCQ | 0.51306973 |
| 112 | RET | 0.50445310 |
| 113 | ERN1 | 0.50234550 |
| 114 | EPHB1 | 0.48481844 |
| 115 | MAP3K10 | 0.47388619 |
| 116 | PIM1 | 0.46663242 |
| 117 | STK24 | 0.46275240 |
| 118 | MAPK12 | 0.45823412 |
| 119 | TTN | 0.45744031 |
| 120 | PDGFRB | 0.45438898 |
| 121 | FGR | 0.45419629 |
| 122 | RIPK1 | 0.44283781 |
| 123 | FYN | 0.41911837 |
| 124 | MAPK3 | 0.41415444 |
| 125 | DMPK | 0.40392888 |
| 126 | TBK1 | 0.37603161 |
| 127 | MAPK11 | 0.36876561 |
| 128 | RPS6KA3 | 0.36385974 |
| 129 | MAP3K6 | 0.36236203 |
| 130 | PRKCB | 0.35994307 |
| 131 | MAP3K2 | 0.35497224 |
| 132 | KSR2 | 0.34649772 |
| 133 | DAPK3 | 0.33865350 |
| 134 | CDK4 | 0.33330176 |
| 135 | PRKACA | 0.31791070 |
| 136 | PTK2 | 0.31444832 |
| 137 | MAPK4 | 0.31147684 |
| 138 | TNK2 | 0.31078539 |
| 139 | MAP2K2 | 0.30649763 |
| 140 | JAK3 | 0.28322280 |
| 141 | ILK | 0.26614485 |
| 142 | TAOK1 | 0.26557391 |
| 143 | CAMK2A | 0.26315684 |
| 144 | MAPK1 | 0.24433631 |
| 145 | CDK5 | 0.24357034 |
| 146 | CSK | 0.23459088 |
| 147 | DAPK2 | 0.20878479 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 3.28781833 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.02257941 |
| 3 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 2.99418276 |
| 4 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.76461782 |
| 5 | Allograft rejection_Homo sapiens_hsa05330 | 2.75734181 |
| 6 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.68512573 |
| 7 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.50342357 |
| 8 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.35338401 |
| 9 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.31651108 |
| 10 | Other glycan degradation_Homo sapiens_hsa00511 | 2.24684810 |
| 11 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.17614499 |
| 12 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.08046025 |
| 13 | Renin-angiotensin system_Homo sapiens_hsa04614 | 10.3501905 |
| 14 | Asthma_Homo sapiens_hsa05310 | 10.0175472 |
| 15 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.91933041 |
| 16 | Mineral absorption_Homo sapiens_hsa04978 | 1.90585573 |
| 17 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.90029451 |
| 18 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.75772206 |
| 19 | Pertussis_Homo sapiens_hsa05133 | 1.58483792 |
| 20 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.56569081 |
| 21 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.53809238 |
| 22 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.45402554 |
| 23 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.44233180 |
| 24 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.40994001 |
| 25 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 1.39473689 |
| 26 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.38908815 |
| 27 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.38123965 |
| 28 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.34816974 |
| 29 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.30783545 |
| 30 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.28763362 |
| 31 | Platelet activation_Homo sapiens_hsa04611 | 1.20179334 |
| 32 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.17911219 |
| 33 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.15922230 |
| 34 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.14978178 |
| 35 | Tuberculosis_Homo sapiens_hsa05152 | 1.14436817 |
| 36 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.13886952 |
| 37 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.03768168 |
| 38 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.03433679 |
| 39 | Cocaine addiction_Homo sapiens_hsa05030 | 1.02682036 |
| 40 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.02488544 |
| 41 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.97638687 |
| 42 | Lysosome_Homo sapiens_hsa04142 | 0.93742479 |
| 43 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.87022554 |
| 44 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.86653613 |
| 45 | Malaria_Homo sapiens_hsa05144 | 0.86486026 |
| 46 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.86452870 |
| 47 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.84821451 |
| 48 | Phagosome_Homo sapiens_hsa04145 | 0.83046226 |
| 49 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.82833078 |
| 50 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.82759996 |
| 51 | Influenza A_Homo sapiens_hsa05164 | 0.81343910 |
| 52 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.81022417 |
| 53 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.78143107 |
| 54 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.77963926 |
| 55 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.76984432 |
| 56 | Retinol metabolism_Homo sapiens_hsa00830 | 0.75590154 |
| 57 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.75295806 |
| 58 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.74887399 |
| 59 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.73845224 |
| 60 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.72281463 |
| 61 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.70356387 |
| 62 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.69623316 |
| 63 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.67652357 |
| 64 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.67141078 |
| 65 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.64470952 |
| 66 | Galactose metabolism_Homo sapiens_hsa00052 | 0.64130383 |
| 67 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.63765304 |
| 68 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.60838021 |
| 69 | Prion diseases_Homo sapiens_hsa05020 | 0.60695865 |
| 70 | Salmonella infection_Homo sapiens_hsa05132 | 0.59196936 |
| 71 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.59041237 |
| 72 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.57604027 |
| 73 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.57467635 |
| 74 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.57115039 |
| 75 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.56554596 |
| 76 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.54617014 |
| 77 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.53647204 |
| 78 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.52891702 |
| 79 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.52778370 |
| 80 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.52413679 |
| 81 | Hepatitis C_Homo sapiens_hsa05160 | 0.52279240 |
| 82 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.51576876 |
| 83 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.50373067 |
| 84 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.49891164 |
| 85 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.47061624 |
| 86 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.44703190 |
| 87 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.44446188 |
| 88 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.44403574 |
| 89 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.43300908 |
| 90 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.42201595 |
| 91 | Histidine metabolism_Homo sapiens_hsa00340 | 0.41620491 |
| 92 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.40414027 |
| 93 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.40318712 |
| 94 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.39282985 |
| 95 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.39136023 |
| 96 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.36967124 |
| 97 | Long-term potentiation_Homo sapiens_hsa04720 | 0.35812226 |
| 98 | Legionellosis_Homo sapiens_hsa05134 | 0.35666509 |
| 99 | Glioma_Homo sapiens_hsa05214 | 0.34755302 |
| 100 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.34476011 |
| 101 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.34424900 |
| 102 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.33947048 |
| 103 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.33795818 |
| 104 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.33673029 |
| 105 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.32551414 |
| 106 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.32372972 |
| 107 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.32054126 |
| 108 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.31155639 |
| 109 | Peroxisome_Homo sapiens_hsa04146 | 0.30848216 |
| 110 | Focal adhesion_Homo sapiens_hsa04510 | 0.29700382 |
| 111 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.29618205 |
| 112 | Leishmaniasis_Homo sapiens_hsa05140 | 0.29378039 |
| 113 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.28910412 |
| 114 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.28307191 |
| 115 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.27968207 |
| 116 | Amoebiasis_Homo sapiens_hsa05146 | 0.27583086 |
| 117 | Hepatitis B_Homo sapiens_hsa05161 | 0.27279020 |
| 118 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.26170009 |
| 119 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.25627974 |
| 120 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.25418439 |
| 121 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.24863106 |
| 122 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.24465041 |
| 123 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.24325910 |
| 124 | Apoptosis_Homo sapiens_hsa04210 | 0.23447463 |
| 125 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.21470917 |
| 126 | Viral myocarditis_Homo sapiens_hsa05416 | 0.20647932 |
| 127 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.20402180 |
| 128 | Bile secretion_Homo sapiens_hsa04976 | 0.20016990 |
| 129 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.19785274 |
| 130 | Colorectal cancer_Homo sapiens_hsa05210 | 0.19780975 |
| 131 | Circadian entrainment_Homo sapiens_hsa04713 | 0.19756955 |
| 132 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.19541215 |
| 133 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.18689828 |
| 134 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.18577417 |
| 135 | Renin secretion_Homo sapiens_hsa04924 | 0.18310726 |
| 136 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.18205091 |
| 137 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.18001355 |
| 138 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.17959422 |
| 139 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.17813664 |
| 140 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.17487519 |
| 141 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.17250368 |
| 142 | Gap junction_Homo sapiens_hsa04540 | 0.17026786 |
| 143 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.16951913 |
| 144 | Insulin resistance_Homo sapiens_hsa04931 | 0.16852212 |
| 145 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.16796199 |
| 146 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.16406461 |
| 147 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.16339574 |
| 148 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.16158796 |
| 149 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.16113947 |
| 150 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.15995530 |
| 151 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.15795487 |
| 152 | Olfactory transduction_Homo sapiens_hsa04740 | 0.15532937 |
| 153 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.15040391 |
| 154 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.14481565 |
| 155 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.14469161 |
| 156 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.14407897 |
| 157 | Pathways in cancer_Homo sapiens_hsa05200 | 0.14086805 |
| 158 | Melanogenesis_Homo sapiens_hsa04916 | 0.13811582 |
| 159 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.13711322 |
| 160 | Morphine addiction_Homo sapiens_hsa05032 | 0.13616582 |
| 161 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.13288514 |
| 162 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.12869305 |
| 163 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.12333998 |
| 164 | Endocytosis_Homo sapiens_hsa04144 | 0.11416633 |
| 165 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.11270083 |

